MedTrace Logo

Procedure Selection in Obesity and Metabolic Surgery Based on EOSS

NCT03556059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9437

Last updated 2019-01-24

No results posted yet for this study

Summary

The Edmonton Obesity Staging System (EOSS) is a more comprehensive measure of obesity-related diseases and predictor of mortality than BMI or waist circumference. EOSS is also important in predicting post - operative outcome and 30-day mortality after metabolic surgery.

The aim of this study is to determine whether EOSS could be an indicator for procedure selection in obesity and metabolic surgery.

Conditions

  • Postoperative Complications

Interventions

OTHER

Role of EOSS

The Edmonton Obesity Staging System (EOSS) is a more comprehensive measure of obesity-related diseases and predictor of mortality than body mass index (BMI) or waist circumference. Its application for the selection of obese patients for obesity surgery has been suggested. This study evaluates the role of the Edmonton Obesity Staging System (EOSS) in predicting postoperative outcome (next to the Clavien Dindo Classification) and 30-day mortality after metabolic surgery.

Sponsors & Collaborators

  • Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie

    collaborator OTHER

  • Sana Klinikum Offenbach

    lead OTHER

Principal Investigators

  • Rudolf Weiner, Prof. · Sana Klinikum Offenbach

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03556059 on ClinicalTrials.gov